Editorial: non-invasive testing for EoE-does microbiome testing hold the key? Authors' reply

Affiliations

¹ Department of Surgery, Oncology and Gastroenterology (DISCOG), University Hospital of Padua, Padua, Italy.
² Department of Biotechnology, University of Verona, Verona, Italy.
³ Department of Medicine, Gastroenterology Unit, University of Verona, Verona, Italy.
⁴ Department of Oncological Gastrointestinal Surgery, Gastroenterology Unit, S. Maria del Prato Hospital, Feltre, Italy.

Editorial

Sonia Facchin et al. Aliment Pharmacol Ther. 2022 Aug.

. 2022 Aug;56(4):729-730.

doi: 10.1111/apt.17144.

¹ Department of Surgery, Oncology and Gastroenterology (DISCOG), University Hospital of Padua, Padua, Italy.
² Department of Biotechnology, University of Verona, Verona, Italy.
³ Department of Medicine, Gastroenterology Unit, University of Verona, Verona, Italy.
⁴ Department of Oncological Gastrointestinal Surgery, Gastroenterology Unit, S. Maria del Prato Hospital, Feltre, Italy.

No abstract available

Comment on

Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects.
Facchin S, Calgaro M, Pandolfo M, Caldart F, Ghisa M, Greco E, Sattin E, Valle G, Dellon ES, Vitulo N, Savarino EV. Facchin S, et al. Aliment Pharmacol Ther. 2022 Aug;56(3):450-462. doi: 10.1111/apt.17091. Epub 2022 Jun 17. Aliment Pharmacol Ther. 2022. PMID: 35715947
Editorial: non-invasive testing for EoE-does microbiome testing hold the key?
Naik RD, Patel DA. Naik RD, et al. Aliment Pharmacol Ther. 2022 Aug;56(4):727-728. doi: 10.1111/apt.17130. Aliment Pharmacol Ther. 2022. PMID: 35879898 No abstract available.

1. Nauk Rishi PD. Editorial: non-invasive testing for EoE - does microbiome testing hold the key? Aliment Pharmacol Ther. 2022;56:725-726.
1. Facchin S, Calgaro M, Pandolfo M, Caldart F, Ghisa M, Greco E, et al. Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects. Aliment Pharmacol Ther. 2022;56:450-462.
1. Frazzoni M, Frazzoni L, De Bortoli N, Russo S, Tolone S, Arsiè E, et al. Response of eosinophilic oesophagitis to proton pump inhibitors is associated with impedance-pH parameters implying anti-reflux mechanism of action. Aliment Pharmacol Ther. 2021;53:1183-1189.
1. Visaggi P, Savarino E, Sciume G, Chio TD, Bronzini F, Tolone S, et al. Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults. Therap Adv Gastroenterol. 2021;14:1756284820980860. https://doi.org/10.1177/1756284820980860
1. Laserna-Mendieta EJ, Casabona S, Guagnozzi D, Savarino E, Perelló A, Guardiola-Arévalo A, et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther. 2020;52:798-807.